PTP4A3 and gastric neoplasm: In addition, targeting of PRL-3 has been proposed and several studies have recently reported endogenous suppressing proteins[19] and a new humanized antibody against PRL3 (PRL3-zumab) has been tested in orthotopic gastric tumors[20].